Breaking News Instant updates and real-time market news.

MNK

Mallinckrodt

$24.33

-0.05 (-0.21%)

04:55
11/28/18
11/28
04:55
11/28/18
04:55

Mallinckrodt management to meet with Leerink

Meetings to be held in Philadelphia on November 27 and in the Mid-Atlantic area on November 28 hosted by Leerink.

  • 28

    Nov

  • 02

    Dec

MNK Mallinckrodt
$24.33

-0.05 (-0.21%)

11/19/18
WELS
11/19/18
NO CHANGE
Target $27
WELS
Market Perform
OIG response to Mallinckrodt's Acthar proposal a negative, says Wells Fargo
The Office of the Inspector General of the Department of Health and Human Services has advised Mallinckrodt (MNK) that the proposed patient access program for Acthar in hospitals would "present more than a minimal risk of fraud and abuse under the anti-kickback statute," Wells Fargo analyst David Maris tells investors in a research note. While not a setback to current Acthar sales, this is a negative outcome in Mallinckrodt's efforts to expand access to the drug, says the analyst. He believes the OIG opinion effectively states that if Mallinckrodt gives Acthar to hospitals for free for a chronic syndrome, and then will provide it for free only to those patients when discharged whose insurance won't pay for it, then the company is effectively giving away a product to help get those with commercial insurance to pay for it when out of the hospital. Maris thinks Mallinckrodt's Acthar faces a "challenging environment" with HHS and OIG. He keeps a Market Perform rating on the shares with a $27 price target.
11/23/18
ADAM
11/23/18
NO CHANGE
Target $40
ADAM
Buy
Mallinckrodt Acthar franchise not impacted by HHS opinion, says Canaccord
Canaccord analyst Dewey Steadman noted Mallinckrodt received an advisory opinion from the HHS denying what appeared to be the company's request to distribute free vials of Acthar to hospitals to encourage use in West syndrome and infantile spasms. The analyst views the opinion as clearly anti-patient and not particularly negative to the IS sub-franchise within Acthar, as the current distribution status quo appears to have been maintained. He sees the weakness in the shares as a chance to build a position in the name. Steadman reiterated his Buy rating and $40 price target on Mallinckrodt shares.
11/27/18
JEFF
11/27/18
NO CHANGE
Target $35
JEFF
Buy
Atlantis study unlikely to impact Mallinckrodt script trends, says Jefferies
Mallinckrodt shares sold off 8% yesterday on a delayed circulation of results from the Atlantis trial, a randomized prospective study aimed at examining safety and efficacy of Acthar in treating pediatric patients with nephrotic syndrome, Jefferies analyst Anthony Petrone tells investors in a research note. The trial was stopped at interim as the majority of participants treated with Acthar experienced a relapse within 23 days, which was similar to the control arm, says the analyst. Hence, Acthar showed no benefit at preventing relapse of nephrotic syndrome in pediatric patients, Petrone notes. The analyst says he confirmed that the Atlantis study was an investigator-led study and was not officially sponsored by the company. He adds that Acthar use in pediatric nephrotic syndrome is minimal and that several other NS study readouts "point toward efficacy in refractive patients." As such, Petrone does not see the Atlantis results as being pivotal in impacting near-term prescription trends or as an indicator of future readouts to come in 2019. He keeps a Buy rating on Mallinckrodt with a $35 price target.
11/27/18
ADAM
11/27/18
NO CHANGE
Target $40
ADAM
Buy
Citron tweet on Mallinckrodt an 'Acthar nothingburger,' says Canaccord
Canaccaord analyst Dewey Steadman tells investors in a research note that yesterday's tweet by Citron Research with a link to an article in Clinical Journal of the American Society of Nephrology that showed Mallinckrodt's Acthar showed little efficacy in pediatric nephrotic syndrome patients is "essentially old news" that is not relevant to the current Acthar franchise. The analyst, who called the news "an Acthar nothingburger," sees robust data in six indications as key drivers to tamp down over-reactions to non-important data reads. The analyst reiterates a Buy rating on Mallinckrodt with a $40 price target and sees an "even better" entry point into the story at these levels.

TODAY'S FREE FLY STORIES

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

11:35
12/14/18
12/14
11:35
12/14/18
11:35
General news
President Trump says 'China wants to make a big' trade deal »

President Donald Trump…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$262.91

-2.5 (-0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNE

Veoneer

$28.28

0.17 (0.60%)

, ALV

Autoliv

$74.47

-1.58 (-2.08%)

11:30
12/14/18
12/14
11:30
12/14/18
11:30
On The Fly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

VNE

Veoneer

$28.28

0.17 (0.60%)

ALV

Autoliv

$74.47

-1.58 (-2.08%)

F

Ford

$8.63

0.13 (1.53%)

GM

General Motors

$35.53

0.42 (1.20%)

BWA

BorgWarner

$34.80

0.34 (0.99%)

APTV

Aptiv

$66.80

0.11 (0.16%)

TSLA

Tesla

$373.15

-3.71 (-0.98%)

WBA

Walgreens Boots Alliance

$79.00

-3.35 (-4.07%)

CVS

CVS Health

$72.40

-0.98 (-1.34%)

RAD

Rite Aid

$0.93

0.0271 (2.99%)

BHC

Bausch Health

$24.05

0.4 (1.69%)

LSCC

Lattice Semiconductor

$6.94

0.31 (4.68%)

REGN

Regeneron

$381.29

2.59 (0.68%)

CSCO

Cisco

$46.34

-1.12 (-2.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 19

    Dec

  • 20

    Dec

  • 10

    Jan

  • 23

    Jan

  • 15

    Feb

  • 25

    Feb

  • 04

    Mar

  • 11

    Mar

  • 25

    Apr

  • 28

    Apr

  • 13

    May

  • 23

    May

  • 24

    Jul

  • 23

    Oct

EBAY

eBay

$29.05

0.06 (0.21%)

11:30
12/14/18
12/14
11:30
12/14/18
11:30
Options
$4.2M premium sale in Ebay options »

$4.2M premium sale in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

CLVS

Clovis

$20.16

-1.48 (-6.84%)

, TSRO

Tesaro

$73.95

-0.51 (-0.68%)

11:28
12/14/18
12/14
11:28
12/14/18
11:28
On The Fly
Clovis drops after Tesaro filing shows interest, but no bids »

Shares of Clovis Oncology…

CLVS

Clovis

$20.16

-1.48 (-6.84%)

TSRO

Tesaro

$73.95

-0.51 (-0.68%)

GSK

GlaxoSmithKline

$37.60

-0.34 (-0.90%)

RHHBY

Roche

$0.00

(0.00%)

AZN

AstraZeneca

$39.07

-0.16 (-0.41%)

BMY

Bristol-Myers

$53.06

-0.59 (-1.10%)

SNY

Sanofi

$44.17

-0.67 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

  • 29

    Dec

  • 17

    Jan

  • 24

    Jan

  • 28

    Jan

  • 11

    Mar

  • 18

    Mar

  • 22

    Mar

  • 28

    Apr

  • 20

    May

11:25
12/14/18
12/14
11:25
12/14/18
11:25
General news
U.S. high yield corporate bond ETFs remain under pressure »

U.S. high yield corporate…

GRUB

GrubHub

$79.38

-0.17 (-0.21%)

, YELP

Yelp

$36.60

0.72 (2.01%)

11:25
12/14/18
12/14
11:25
12/14/18
11:25
Conference/Events
Wedbush restaurants analyst to hold an analyst/industry conference call »

Smid Internet Analyst…

GRUB

GrubHub

$79.38

-0.17 (-0.21%)

YELP

Yelp

$36.60

0.72 (2.01%)

BWLD

Taken private 2/18

$0.00

(0.00%)

CAKE

Cheesecake Factory

$45.42

-0.42 (-0.92%)

BJRI

BJ's Restaurants

$54.66

0.08 (0.15%)

CMG

Chipotle

$469.59

-3.45 (-0.73%)

JACK

Jack in the Box

$81.20

-1.29 (-1.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 06

    Feb

ATOM

Atomera

$3.30

(0.00%)

11:25
12/14/18
12/14
11:25
12/14/18
11:25
Conference/Events
Atomera participates in a conference call with Loop Capital »

Technology Analyst Acree…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

GIB

CGI Group

$63.42

-0.43 (-0.67%)

11:25
12/14/18
12/14
11:25
12/14/18
11:25
Conference/Events
CGI Group management to meet with RBC Capital »

Group luncheon with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

BJRI

BJ's Restaurants

$54.66

0.08 (0.15%)

, BLMN

Bloomin' Brands

$18.53

-0.11 (-0.59%)

11:25
12/14/18
12/14
11:25
12/14/18
11:25
Conference/Events
William Blair apparel/accessories analyst to hold a group luncheon »

Apparel & Accessories…

BJRI

BJ's Restaurants

$54.66

0.08 (0.15%)

BLMN

Bloomin' Brands

$18.53

-0.11 (-0.59%)

BOJA

Bojangles

$16.04

(0.00%)

CAKE

Cheesecake Factory

$45.42

-0.42 (-0.92%)

CCL

Carnival

$56.47

-0.13 (-0.23%)

CMG

Chipotle

$469.59

-3.45 (-0.73%)

CVNA

Carvana

$33.56

0.07 (0.21%)

DNKN

Dunkin' Brands

$69.53

-1.32 (-1.86%)

HOG

Harley-Davidson

$34.94

0.01 (0.03%)

KMX

CarMax

$62.06

-0.305 (-0.49%)

LOCO

El Pollo Loco

$15.32

-0.13 (-0.84%)

LULU

Lululemon

$120.95

0.74 (0.62%)

PBPB

Potbelly

$9.40

0.03 (0.32%)

PLAY

Dave & Buster's

$46.14

-0.06 (-0.13%)

PLNT

Planet Fitness

$54.94

0.56 (1.03%)

RCL

Royal Caribbean

$107.10

1.99 (1.89%)

SBUX

Starbucks

$65.22

-1.68 (-2.51%)

SHAK

Shake Shack

$46.75

0.42 (0.91%)

SONC

Sonic

$0.00

(0.00%)

TLYS

Tilly's

$10.81

0.21 (1.98%)

UAA

Under Armour

$19.24

0.475 (2.53%)

ZOES

Zoe's Kitchen

$0.00

(0.00%)

ZUMZ

Zumiez

$18.76

0.44 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 20

    Dec

  • 21

    Dec

  • 14

    Jan

  • 15

    Jan

  • 06

    Feb

POAHY

Porsche

$0.00

(0.00%)

, BMWYY

BMW

$0.00

(0.00%)

11:22
12/14/18
12/14
11:22
12/14/18
11:22
Hot Stocks
Porsche, BMW unveil EV charging station with output of up to 450 kW »

Porsche (POAHY) said…

POAHY

Porsche

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

SIEGY

Siemens

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETFC

E-Trade

$44.77

0.51 (1.15%)

11:20
12/14/18
12/14
11:20
12/14/18
11:20
Options
Three-way put spread in Etrade as shares move up from 52-week lows »

Three-way put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
12/14/18
12/14
11:17
12/14/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
12/14/18
12/14
11:16
12/14/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AABA

Altaba

$61.41

-1.33 (-2.12%)

11:15
12/14/18
12/14
11:15
12/14/18
11:15
Options
Altaba Inc put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:12
12/14/18
12/14
11:12
12/14/18
11:12
Conference/Events
Deutsche Bank autos & auto tech analyst to hold a group luncheon »

Autos & Auto Tech…

ABT

Abbott

$71.32

-0.87 (-1.21%)

11:10
12/14/18
12/14
11:10
12/14/18
11:10
Hot Stocks
Abbott raises quarterly dividend 14% to 32c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARNC

Arconic

$19.88

-0.06 (-0.30%)

11:05
12/14/18
12/14
11:05
12/14/18
11:05
Options
Arconic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLVS

Clovis

$20.05

-1.59 (-7.35%)

, TSRO

Tesaro

$73.97

-0.49 (-0.66%)

11:03
12/14/18
12/14
11:03
12/14/18
11:03
Recommendations
Clovis, Tesaro, GlaxoSmithKline analyst commentary  »

Tesaro proxy documents…

CLVS

Clovis

$20.05

-1.59 (-7.35%)

TSRO

Tesaro

$73.97

-0.49 (-0.66%)

GSK

GlaxoSmithKline

$37.55

-0.39 (-1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRU

TransUnion

$60.71

-0.55 (-0.90%)

10:55
12/14/18
12/14
10:55
12/14/18
10:55
Conference/Events
TransUnion management to meet with William Blair »

Group Luncheon Meetings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Feb

GM

General Motors

$35.33

0.22 (0.63%)

10:52
12/14/18
12/14
10:52
12/14/18
10:52
Hot Stocks
General Motors says 2,400 jobs to be open in Durham Region in 2019, 2020 »

General Motors Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$47.50

3.17 (7.15%)

10:50
12/14/18
12/14
10:50
12/14/18
10:50
Options
XPO Logistics options remain active as shares rebound from 52-week lows »

XPO Logistics options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEGH

Legacy Housing

$0.00

(0.00%)

10:47
12/14/18
12/14
10:47
12/14/18
10:47
Syndicate
Breaking Syndicate news story on Legacy Housing »

Legacy Housing opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

LEGH

Legacy Housing

$0.00

(0.00%)

10:45
12/14/18
12/14
10:45
12/14/18
10:45
Syndicate
Breaking Syndicate news story on Legacy Housing »

Legacy Housing indicated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

10:45
12/14/18
12/14
10:45
12/14/18
10:45
General news
Fed Policy Outlook: there should be little doubt about a 25 bp rate hike Wednesday »

Fed Policy Outlook: there…

AAPL

Apple

$166.39

-4.54 (-2.66%)

10:44
12/14/18
12/14
10:44
12/14/18
10:44
Technical Analysis
Technical Take: Apple in bearish pattern, levels to watch »

On the daily chart a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.